Lipid Profile in Diabetic and Non Diabetic CKD Patients
NCT ID: NCT06802978
Last Updated: 2025-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2025-02-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question this study aims to answer is:
Does having diabetes make fat problems worse in people with chronic kidney disease (CKD), or is there no connection between them?
Researchers will compare the blood lipid (fat) levels in people with chronic kidney disease (CKD) who have diabetes and those without diabetes to see if having diabetes makes lipid problems worse in CKD patients, or if there is no connection between diabetes and changes in lipid levels.
Participants will need to fast for 10 hours before undergoing this test. This means not eating any food or drinking anything except water.
Samples will be taken and sent to laboratory immediately.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk of CKD in Diabetic Patients With MAFLD
NCT06304844
Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients.
NCT04380584
Prediabetes in End Stage Renal Disease on Dialysis
NCT07337083
Prevent Diabetic Kidney Disease Among Egyptians
NCT06071208
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic CKD patients
This group includes participants aged over 20 years who have been diagnosed with both chronic kidney disease (CKD) and diabetes mellitus.
No interventions assigned to this group
Non-diabetic CKD patients
participants aged over 20 years who have been diagnosed with chronic kidney disease (CKD) but do not have a current or past diagnosis of diabetes mellitus.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged above 20 years of age.
* All patients who have given consent for enrolling into the study.
Exclusion Criteria
* Patients on lipid-lowering drugs.
* Kidney transplanted patients.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaimaa Mahmoud Elsayed Abdel-Raheem
Principal investigator resident at the Internal Medicine Department, Sohag University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Internal Medicine , Sohag University Hospital.
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Mahmoud Ibrahim Yousef
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mahmoud Ibrahim Yousef
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med--25-1-07MS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.